Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Did a simple phone call keep chronic patients out of the hospital?

NCT ID NCT04359875

Knowledge-focused Sponsor: University Hospital, Tours Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a systematic phone call from a medical student, supervised by a general practitioner, could reduce hospitalizations in patients with chronic heart or mental health conditions during the COVID-19 lockdown in France. Over 22,000 patients aged 70 and older were enrolled. The goal was to see if proactive outreach could catch problems early and prevent emergency care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
phone-call screening and management by a medical student/general practitioner team
What this could lead to
If successful, this approach could show that simple phone check-ins help keep vulnerable patients out of the hospital during crises.
What could go wrong
This is a completed trial, but its findings may not apply to other settings or diseases. The intervention was tested only during a unique pandemic period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

22,000 people

The number who actually took part.

Started

Apr 2020

Finished

Dec 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 110 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria (patient with a chronic cardiovascular) : * Male or female * \>= 70 years of age * Participants covered by or entitled to social security * With a chronic cardiovascular or mental disease as referenced in the long term illness (ALD) list (i.e. with an ALD n°1, 3, 5, 12, 13 for cardiovascular disease) * Followed regularly by their general practitioner (i.e. entered in the list of patients followed by a general practitioner by French Health Insurance * Participants who has given oral, express and informed consent. Inclusion criteria (patient with a mental disease) : * Male or female * \>= 18 years of age * Participants covered by or entitled to social security * With a chronic cardiovascular or mental disease as referenced in the long term illness (ALD) list (i.e. with an ALD 23 for mental disease) * Followed regularly by their general practitioner (i.e. entered in the list of patients followed by a general practitioner by French Health Insurance * Participants who has given oral, express and informed consent Exclusion criteria : * Patients with both a cardiovascular ALD and a mental health ALD (they will benefit from the intervention, without participating in the trial) * Patients already and directly managed by their general practitioner during containment and whose general practitioner refuses that the patient be contacted by someone other than himself * Patients unable to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Chronic Disease COVID-19 mental disorder psychiatric disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular diseases Mental disorder

Contacts and locations

Locations

  • Dibao-Dina

    Tours, 37000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.